Dual-agent immunotherapy for prevention of melanoma brain metastases: A real-world analysis of 8686 patients.

被引：0
|
作者：
Mansouri, Alireza
Bhanja, Debarati
Wilding, Hannah E.
Mikolajewicz, Nicholas
Ozair, Ahmad
Ahluwalia, Manmeet Singh
机构：
[1] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[2] Penn State Coll Med, Hershey, PA USA
[3] Penn State Coll Med, University Pk, PA USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Miami Canc Inst, Baptist Hlth South Florida, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2022
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis
    O'Brien, Diana A. Roth
    Kaye, Sydney M.
    Poppas, Phillip J.
    Mahase, Sean S.
    An, Anjile
    Christos, Paul J.
    Liechty, Benjamin
    Pisapia, David
    Ramakrishna, Rohan
    Wernicke, A. G.
    Knisely, Jonathan P. S.
    Pannullo, Susan C.
    Schwartz, Theodore H.
    JOURNAL OF NEUROSURGERY, 2021, 135 (06) : 1695 - 1705
  • [32] Real-world outcome analysis of EGFR-mutated lung adenocarcinoma with brain metastases.
    Kuan, Fens-Che
    Yang, Wei-Hsun
    Lai, Hung-Yi
    Huang, Chun-Chieh
    Yang, Cheng-Ta
    Shi, Chung-Shang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Treatment patterns and outcomes in BRAF V600E mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting
    Gibney, Geoffrey Thomas
    Marynchenko, Maryna
    Galebach, Philip J.
    Ayas, Charles
    Liu, Nathan S.
    Wu, Eric Qiong
    Yim, Yeun Mi
    Abhyankar, Sarang S.
    Reyes, Carolina M.
    Guerin, Annie
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Real-World Analysis of Venous Thromboembolism Prevention in US Patients with Ischemic Stroke
    Amin, Alpesh N.
    Lin, Jay
    Wiederkehr, Daniel
    ANNALS OF NEUROLOGY, 2010, 68 (04) : S7 - S8
  • [35] Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting
    Gibney, Geoffrey T.
    Gauthier, Genevieve
    Ayas, Charles
    Galebach, Philip
    Wu, Eric Q.
    Abhyankar, Sarang
    Reyes, Carolina
    Guerin, Annie
    Yim, Yeun Mi
    CANCER MEDICINE, 2015, 4 (08): : 1205 - 1213
  • [36] Real-world outcomes of immunotherapy regimens in first line non small cell lung cancer in lebanese patients.
    Nasr, Lewis
    Diab, Saada
    Ghoche, Ahmad
    Yehia, Intissar
    Nasr, Fadi Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18741 - E18741
  • [37] Survival of melanoma patients treated with novel drugs: retrospective analysis of real-world data
    Marta Polkowska
    Paweł Ekk-Cierniakowski
    Edyta Czepielewska
    Wojciech Wysoczański
    Wojciech Matusewicz
    Małgorzata Kozłowska-Wojciechowska
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2087 - 2094
  • [38] Survival of melanoma patients treated with novel drugs: retrospective analysis of real-world data
    Polkowska, Marta
    Ekk-Cierniakowski, Pawel
    Czepielewska, Edyta
    Wysoczanski, Wojciech
    Matusewicz, Wojciech
    Kozlowska-Wojciechowska, Malgorzata
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (10) : 2087 - 2094
  • [39] The efficacy of novel antibody-drug-conjugates on brain metastases in metastatic breast cancer patients - a multicenter real-world analysis
    Dannehl, Dominik
    Schaffler, Henning
    Engler, Tobias
    Volmer, Lea
    Estler, Arne
    Popp, Ilinca
    Lorenz, Stefanie
    Grischke, Eva-Maria
    Hahn, Markus
    Tabatabai, Ghazaleh
    Juhasz-Boss, Ingolf
    Janni, Wolfgang
    Brucker, Sara
    Taran, Florin-Andrei
    Hartkopf, Andreas
    CANCER RESEARCH, 2024, 84 (09)
  • [40] Real-world analysis of ICI efficacy in ES-SCLC patients with and without brain metastases: A call for inclusion in clinical trials
    Cao, Yuanzhen
    Afzal, Muhammad Zubair
    Lu, Ziyao
    Sharma, Aditya
    Pirruccello, Jonathan P.
    Shirai, Keisuke
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345